Jean-Guillaume Dillinger Selected Research

Jean-Guillaume Dillinger Research Topics

6	Acute Coronary Syndrome 01/2022 - 10/2012
5	Hemorrhage 10/2021 - 01/2018
4	ST Elevation Myocardial Infarction 10/2021 - 01/2016
4	Myocardial Infarction 01/2021 - 04/2012
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 02/2011
3	Thrombosis (Thrombus) 04/2019 - 12/2013
3	Out-of-Hospital Cardiac Arrest 01/2016 - 04/2012
2	Diabetes Mellitus 05/2022 - 05/2015
2	Necrosis 11/2020 - 04/2019
2	Heart Arrest (Cardiac Arrest) 06/2018 - 01/2018
2	Coma (Comas) 01/2016 - 04/2012
1	Non-ST Elevated Myocardial Infarction 01/2022
1	Unstable Angina 10/2021
1	Vascular System Injuries 01/2021
1	Neoplasms (Cancer) 12/2018
1	Ventricular Fibrillation 06/2018
1	Shock 06/2018
1	Stroke (Strokes) 02/2018
1	Thromboembolism 02/2018
1	Body Weight (Weight, Body) 02/2018
1	Embolism (Embolus) 02/2018
1	Atrial Fibrillation 02/2018
1	Venous Thromboembolism 01/2018
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2018
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2018
1	Thrombophilia 01/2018
1	Coronary Vasospasm (Coronary Artery Vasospasm) 06/2015
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 05/2015
1	Essential Thrombocythemia 01/2012

6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2016 - 02/2011
5	Biological ProductsIBA 01/2018 - 02/2011
4	TicagrelorIBA 10/2021 - 09/2014
3	Clopidogrel (Plavix)FDA Link 10/2021 - 01/2020
3	AnticoagulantsIBA 12/2018 - 01/2018
2	Prasugrel Hydrochloride FDA Link 10/2021 - 09/2014
2	Troleandomycin (TAO)FDA Link 01/2021 - 01/2018
2	Eptifibatide (Integrilin)FDA Link 01/2021 - 01/2018
2	otamixabanIBA 01/2021 - 01/2018
2	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 01/2018
2	AntithrombinsIBA 04/2019 - 01/2018
1	Insulin (Novolin)FDA Link 05/2022
1	CalciumIBA 01/2022
1	AntibodiesIBA 01/2021
1	Troponin T (Troponin T1)IBA 04/2019
1	Thrombin FDA Link 04/2019
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2018
1	Epinephrine (Adrenaline)FDA LinkGeneric 06/2018
1	CatecholaminesIBA 06/2018
1	RivaroxabanIBA 02/2018
1	Pharmaceutical PreparationsIBA 02/2018
1	apixabanIBA 02/2018
1	N(4)-oleylcytosine arabinosideIBA 02/2018
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 02/2018
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	factor V LeidenIBA 01/2018
1	Prothrombin (Factor II)IBA 01/2018
1	Protein CIBA 01/2018
1	Morphine (MS Contin)FDA LinkGeneric 01/2016
1	IvabradineIBA 12/2015
1	SolutionsIBA 06/2015
1	Fibrinogen (Factor I)FDA Link 05/2015
1	von Willebrand FactorIBA 05/2015
1	Arachidonic Acid (Vitamin F)IBA 05/2015
1	TroponinIBA 04/2012

6	Percutaneous Coronary Intervention 01/2021 - 10/2012
3	Stents 01/2020 - 12/2013
2	Cardiopulmonary Resuscitation (CPR) 06/2018 - 04/2012
2	Extracorporeal Membrane Oxygenation 06/2018 - 01/2018
1	Drug Therapy (Chemotherapy) 12/2018
1	Polypharmacy 02/2018
1	Induced Hypothermia 01/2016
1	Therapeutics 12/2015
1	Secondary Prevention 05/2015